Elevance has added a former Pfizer executive to its board, the latest addition of pharmaceutical industry veteran as the insurer focuses on building its pharmacy services. Amy Schulman will start as ...
Nov 13 (Reuters) - Mikael Dolsten, Pfizer's (PFE.N), opens new tab former research and development chief, has withdrawn his candidacy for Novo Nordisk's (NOVOb.CO), opens new tab board, citing ...
Hosted on MSN
Pfizer CEO vows company will be a ‘formidable competitor’ in booming weight-loss market after $10B buy
Pfizer Inc. is doubling down on the booming weight-loss drug race, with CEO Albert Bourla declaring the company will be a "formidable competitor" after securing a $10 billion deal to acquire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback